DuPont downgraded from Strong Buy to Buy amid Q3 guidance and currency concerns despite solid Q2 results.

DuPont remains undervalued but has been downgraded from Strong Buy to Buy due to concerns over its Q3 guidance and currency headwinds. The company is expected to slightly beat Q2 estimates, driven by strong performance in healthcare and aerospace, although softness continues in the construction sector within Diversified Industrials. Management's confidence is shown by a recent $275 million accelerated share repurchase, supported by strong earnings per share growth and margin expansion. However, risks persist in the business technologies and water segments, and broad-based growth is necessary for the stock's multiple to expand further.